In summary, our findings indicate that genetic deficiency of SERT as well as inhibition of SERT by SSRI lead to abnormal fat deposition in WAT and BAT, glucose intolerance and insulin resistance in vivo. This evidence concerns the gene SLC6A4 and Glucose intolerance.